News

6Feb, 2018

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection

Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection Open Acc J Oncol Med 2018. Abstract  Somatic mutations have been perceived as the causal event in the origin of the vast majority of cancers. Advanced massively parallel, high-throughput DNA sequencing have enabled the comprehensive characterization of somatic mutations in a large [...]

12Jan, 2018

Pre-Analytical Assessment of Circulating Cell-Free DNA Prepared by An Isolation-Free Enrichment Technology

Publication: ACTA Scientific Cancer Biology Volume 2 Issue 1 January 2018 Abstract Quantity and quality of circulating cell-free DNA (cfDNA) from plasma is highly variable, with frequent contamination of larger, genomic DNA as a consequence of hemolysis during blood processing. Due to the inherent variability of cfDNA, it is imperative [...]

11Jan, 2018

2018 Research Confirms Circulogene’s Clean Technology

Circulogene's Chief Scientific Officer, Dr. Chen-Hsiung Yeh, authored the latest research findings in ACTA Scientific Cancer Biology, Volume 2, Issue 1. This is the first paper released in 2018, which has important findings that include: Confirming, once again, Circulogene's technology outperforms QIAGEN kit in both quality and quantity; Especially critical is that [...]